Physician profile
Jorge Fleites
NPI 1508899709
$3,102.91
in general payments reported to CMS, 2019-2025
17 companies · $17.38 in 2025
The $17.38 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $266 · 2020: $479 · 2021: $369 · 2022: $502 · 2023: $461 · 2024: $1,008 · 2025: $17.38.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,470 · Education: $17.38.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,469.71 |
| Education | $17.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $608.94 | 2020-2022 | |
| Idorsia Pharmaceuticals US INC | $479.71 | 2022-2024 | Quviviq |
| Jazz Pharmaceuticals INC. | $396.85 | 2021-2024 | |
| Novo Nordisk INC | $249.90 | 2022-2024 | |
| Harmony Biosciences LLC | $206.44 | 2023-2024 | Wakix |
| Ethicon INC. | $168.09 | 2024 | Monarch Platform |
| Pfizer INC. | $141.35 | 2019-2020 | |
| Edwards Lifesciences Corporation | $140.34 | 2024 | |
| Pharmacyclics LLC, An Abbvie Company | $125.00 | 2023 | Imbruvica |
| Janssen Pharmaceuticals, INC | $124.99 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $123.51 | 2020 | |
| Metuchen Pharmaceuticals | $118.72 | 2019 | |
| Eisai INC. | $114.54 | 2020 | |
| Medtronic, INC. | $58.85 | 2024 | Azure Xt Dr Mri Surescan |
| Insmed, INC. | $17.38 | 2025 | Brinsupri |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $14.65 | 2022 | |
| Corcept Therapeutics | $13.65 | 2024 | Korlym |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jorge Fleites listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.